![]() |
市场调查报告书
商品编码
1754012
2025 年至 2033 年眼科雷射市场报告(按产品、适应症、最终用户和地区)Ophthalmic Lasers Market Report by Product, Indication, End-User, and Region 2025-2033 |
2024年,全球眼科雷射器市场规模达13.2亿美元。展望未来, IMARC Group预计到2033年,该市场规模将达到19.4亿美元,2025-2033年期间的复合年增长率(CAGR)为4.15%。微创手术需求的不断增长、飞秒雷射在白内障手术中的应用日益广泛以及眼科疾病患病率的上升是推动市场增长的一些关键因素。
眼部疾病盛行率不断上升
视力相关疾病病例的增加是市场成长的主要动力。例如,根据世界卫生组织 2021 年的数据,全球至少有 22 亿人患有近距离视力或远端视力障碍。世卫组织也表示,视力障碍为全球带来了与未矫正近视(2,440 亿美元)和老花眼(254 亿美元)造成的视力障碍相关的经济负担。 2022 年 1 月,世界经济论坛的新闻稿指出,近视发病率显着上升。到 2050 年,预测全球一半人口将患有近视。此外,根据世界卫生组织 2021 年 10 月的新闻稿,约有 8,840 万人因未解决的屈光不正而失明。除此之外,全球老年人口的增加使老年人更容易患上眼部疾病,这进一步刺激了眼科雷射市场的需求。例如,目前美国约有6,200万65岁及以上成年人,占总人口的18%。 2054年,65岁以上成年人将达到8,400万,占总人口的23%。
技术进步
雷射技术的不断进步,尤其是在精度、速度和安全性等方面,正在推动眼科雷射在各种眼部疾病中的应用。此外,飞秒雷射技术在LASIK、白内障手术和角膜移植等精准微创手术中的应用日益广泛,为整个市场提供了丰厚的成长机会。同时,各大主要市场参与者纷纷推出采用先进技术的眼科雷射器,以增强诊断、治疗计画和个人化病患照护。例如,2022年4月,Nova Eye Medical在欧洲和亚太地区推出了其下一代小梁成形术设备iTrack Advance。 iTrack Advance的功能包括原厂iTrack设备专有的照明光纤尖端,使外科医生能够持续监测设备在施莱姆氏管中的位置。同样,同月和同年,Lumibird Group推出了Capsulo Nd:YAG雷射。该设备旨在打造一个完全整合的多功能雷射平台,实现高效精准的囊切开术和虹膜切开术。因此,此类倡议预计将在未来几年推动眼科雷射市场的收入成长。
拓展产品应用,超越传统视力矫正
眼科雷射应用的多样化超越了传统的视力矫正范围,包括治疗糖尿病视网膜病变、老年黄斑部病变 (AMD) 和视网膜静脉阻塞等视网膜疾病,这也催化了全球眼科雷射市场的成长。在糖尿病视网膜病变中,雷射光凝固术通常用于封闭渗漏的血管或破坏可能导致视力丧失的异常血管。此外,糖尿病视网膜病变病例的增加正在推动眼科雷射市场份额的成长。例如,根据 IMARC 的数据,全球糖尿病视网膜病变市场规模在 2023 年达到 81 亿美元。展望未来, IMARC Group预计到 2032 年市场规模将达到 130 亿美元,在 2024-2032 年期间的复合年增长率 (CAGR) 为 5.2%。同样,眼科雷射在老年性黄斑部病变(AMD)治疗中的应用日益增多,用于靶向和封闭异常血管,从而降低视力进一步恶化的风险,也促进了市场的成长。例如,根据2020年8月发表在《英国眼科学杂誌》上的一篇研究文章,在欧洲,老年性黄斑部病变 (AMD) 是视力障碍和失明的主要原因。欧洲约有6700万人患有老年性黄斑部病变 (AMD)。根据眼科雷射市场预测,视网膜疾病患者数量的成长与市场成长成正比。
The global ophthalmic lasers market size reached USD 1.32 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 1.94 Billion by 2033, exhibiting a growth rate (CAGR) of 4.15% during 2025-2033. Increasing demand for minimally invasive procedures, growing adoption of femtosecond lasers for cataract surgery, and rising prevalence of ophthalmic disorders are some of the key factors driving the market growth.
Increasing Prevalence of Eye Disorders
The increasing cases of vision-related disorders are primarily driving the growth of the market. For instance, according to the WHO 2021, at least 2.2 billion people had near or distant vision impairment across the globe. WHO also stated that vision impairment poses a global financial burden associated with vision impairment from uncorrected myopia (US$ 244 Billion) and presbyopia (US$ 25.4 billion). In January 2022, a press release by the World Economic Forum indicated that rates of short-sightedness (myopia) rose significantly. By 2050, it's even predicted that half of the world's population will be short-sighted. Moreover, according to the October 2021 press release by the World Health Organization, approximately 88.4 million people suffered blindness due to unaddressed refractive errors. Besides this, the rising geriatric population across the globe, who are more prone to developing eye disorders, is further catalyzing the ophthalmic lasers market demand. For instance, there are currently roughly 62 million adults aged 65 and older living in the U.S., accounting for 18% of the population. By 2054, 84 million adults aged 65 and older will make up an estimated 23% of the population.
Technological Advancements
Ongoing advancements in laser technology, particularly in areas such as precision, speed, and safety, are driving the adoption of ophthalmic lasers for various eye conditions. Moreover, the increasing adoption of femtosecond laser technology for precise and minimally invasive procedures such as LASIK, cataract surgery, and corneal transplantation is offering lucrative growth opportunities to the overall market. In line with this, various key market players are launching ophthalmic lasers with advanced technologies for enhanced diagnostics, treatment planning, and personalized patient care. For instance, in April 2022, Nova Eye Medical launched its next-generation canaloplasty device, iTrack Advance, in Europe and Asia-Pacific. The iTrack Advance features include a proprietary illuminated fiber optic tip of the original iTrack device to allow the surgeon to continuously monitor the location of the device in Schlemm's canal. Similarly, in the same month and year, Lumibird Group launched the Capsulo Nd: YAG laser. The device is designed to be a fully integrated, versatile laser platform, enabling efficient and accurate capsulotomy and iridotomy treatments. Thus, such initiatives are expected to propel the ophthalmic lasers market revenue in the coming years.
Expanding Product Application Beyond Traditional Vision Correction
The diversification of ophthalmic laser applications beyond traditional vision correction, including treatment of retinal disorder, such as diabetic retinopathy, age-related macular degeneration (AMD), and retinal vein occlusion, is also catalyzing the growth of the global ophthalmic lasers market. In diabetic retinopathy, laser photocoagulation is commonly used to seal leaking blood vessels or to destroy abnormal blood vessels that may be causing vision loss. Moreover, the rising cases of diabetic retinopathy are propelling the ophthalmic lasers market share. For instance, according to IMARC, the global diabetic retinopathy market size reached US$ 8.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 13.0 Billion by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032. Similarly, the escalating utilization of ophthalmic lasers in AMD to target and seal abnormal blood vessels, reducing the risk of further vision deterioration, is also contributing to the market growth. For instance, according to a research article published in the British Journal of Ophthalmology in August 2020, in Europe, age-related macular degeneration (AMD) is the main cause of visual impairment and blindness. About 67 million people in Europe are affected by age-related macular degeneration (AMD). As per the ophthalmic lasers market forecast, the increasing number of individuals with retinal disorders is directly proportional to market growth.
Femtosecond lasers account for the majority of the global market share
The ophthalmic lasers market report has provided a detailed breakup and analysis of the market based on the product. This includes diode lasers, femtosecond lasers, excimer lasers, Nd: YAG lasers, SLT lasers, and others. According to the report, femtosecond lasers account for the majority of the global market share.
Femtosecond lasers are ultrafast laser systems that emit pulses lasting femtoseconds (10^-15 seconds). They find extensive use in various fields, such as ophthalmology for LASIK surgery, where they precisely reshape corneal tissue, leading to improved vision correction outcomes. Furthermore, femtosecond lasers are pivotal in scientific research, facilitating studies on ultrafast phenomena, such as molecular dynamics and quantum interactions. Their unique properties, including high peak power and ultrashort pulses, make them indispensable tools across diverse applications, promising advancements in medicine, technology, and fundamental science.
Refractive error corrections currently exhibit a clear dominance in the market
Ophthalmic lasers play a crucial role in correcting refractive errors, such as myopia, hyperopia, and astigmatism. In procedures like LASIK (Laser-Assisted In Situ Keratomileusis) and PRK (Photorefractive Keratectomy), these lasers reshape the cornea to adjust its focusing power, thereby improving the vision. An article published in the Journal of Annals of Medicine and Surgery in December 2021 indicated that refractive errors are the most common vision problem and prove to be a significant health issue. Similarly, according to the October 2021 press release by the World Health Organization, approximately 88.4 million people suffer blindness due to unaddressed refractive errors. Such rising cases of refractive errors are anticipated to propel the ophthalmic lasers market's recent price in the coming years.
Hospitals hold the largest market share
Hospitals serve as a crucial hub for the adoption and utilization of these advanced technologies. Moreover, hospitals invest in state-of-the-art ophthalmic laser systems to offer cutting-edge treatments for various eye conditions such as cataracts, glaucoma, and refractive errors. Additionally, hospitals provide a platform for ophthalmologists and eye surgeons to perform surgeries and procedures involving ophthalmic lasers, ensuring access to comprehensive eye care for patients. The presence of these advanced technologies in hospitals contributed to improved patient outcomes, enhanced surgical precision, and expanded treatment options in the field of ophthalmology.
North America currently dominates the global market
The rise in the adoption of highly advanced techniques and systems in the manufacturing of ophthalmic lasers and the technological advancements made in ophthalmic lasers are primarily bolstering the growth of the market in the North American region. Moreover, the rising cases of eye disorders in the region are offering lucrative growth opportunities to the market. For instance, a press release published in February 2022 by the Centers for Disease Control and Prevention (CDC) offered prevalence estimates for the most common eye disorders and eye diseases. Nearly 12 million adults in the United States who were 40 years and above of age had vision impairment, with about a million of them being blind. Besides this, the concerned regulatory authorities are also expediting the approval process for laser technologies, which is further creating a positive outlook for the market. For instance, in December 2021, LASEROPTEK Co., Ltd. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its PicoLO Premium picosecond pulse Nd: YAG laser. The approvals of such innovative products in the United States are positively impacting the ophthalmic lasers market outlook.